Pharma Foods cuts FY July 2026 sales forecast, raises operating profit outlook to JPY 2.6 billion
Reuters2026/09/09 02:01- Pharma Foods cut FY ended July 2026 net sales forecast to JPY 63.2 billion from JPY 67 billion.
- Operating profit outlook raised to JPY 2.6 billion from JPY 2 billion; ordinary profit lifted to JPY 2.4 billion from JPY 2 billion.
- Net income attributable to owners forecast at JPY 1.95 billion, up from JPY 1.5 billion; EPS seen at JPY 67.14 versus JPY 51.65.
- Sales expected to miss on lower revenue, while profit beats reflect tighter cost control and a shift toward profitability and capital efficiency.
- Stronger demand cited for PharmaGABA overseas, steady Newmo Series sales, growth in newer B2C products, and rising interest in ovoveil.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The higher the yen rises, the more retail investors short! 3.61 trillion yen short bets defy the trend, triggering a short squeeze warning
Even though the yen has reached its highest level in months, Japanese retail investors continue to bet that its sharp rebound will come to an end, and are consistently increasing their short positions.
EUR/USD Price Forecast: Bullish bias remains above 1.1600 ahead of ECB and US inflation
Abraxas Capital hedges $353M ETH short with $32M buy – Here’s why
Pons propels Robinhood Chain fees to record $6 million in daily fees as DEX volume doubles
Crypto prices
More
